Measurement of serum IgG4 levels by an established ELISA system and its clinical applications in autoimmune diseases

Abstract

IgG4-related disease (IgG4-RD) is a novel and rare autoimmune disease entity. Elevated serum IgG4 level is strongly suggestive of IgG4-RD. But it is still unknown whether serum IgG4 elevation commonly occurs in other autoimmune diseases. In this study, the serum IgG4 levels were detected by an established enzyme-linked immunosorbent assay (ELISA) in a variety of autoimmune diseases including systemic lupus erythematosus (SLE), Sjogren’s syndrome (SS), polymyositis or dermatomyositis (PM/DM) and IgG4-RD. To evaluate the reliability of this ELISA system, some of our samples were sent to a lab in Kanazawa Medical University, Japan, and detected by using the nephelometric assay. The results showed that our findings were consistent with theirs. Moreover, it was found that the serum IgG4 levels were 0.23±0.16 g/L in 53 healthy controls, 0.16±0.15 g/L in 103 SLE patients, 0.22±0.18 g/L in 41 SS patients and 0.40±0.32 g/L in 21 PM/DM patients. No significant difference in the serum IgG4 level was observed among these groups (P>0.05). The serum IgG4 levels of two cases of IgG4-RD were 1.63 and 4.65 g/L respectively, and both decreased markedly after treatment with glucocorticoids. These data indicated that this established ELISA system can be used for detecting serum IgG4 levels. Elevated serum IgG4 levels help diagnose IgG4-RD and evaluate the curative effect of this condition rather than other autoimmune diseases.

Keywords

IgG4-related disease / IgG4 / enzyme-linked immunosorbent assay / autoimmune disease

References

[1] DivatiaM, KimSA, RoJY. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system dis ease. Yonsei Med J, 2012, 53(1): 15-34

[2] ItoM, NarukeY, MiharaY, et al.. Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease. Pathol Int, 2011, 61(10): 589-592

[3] UmeharaH. A new clinical entity: IgG4-related disease (IgG4-RD) discovered in the 21st century. Intern Med, 2012, 51: 821-822

[4] OkazakiK, UmeharaH. Are classification criteria for IgG4-RD now possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol, 2012, 2012: 357071

[5] Morselli-LabateAM, PezzilliR. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol, 2009, 24(1): 15-36

[6] StoneJ H, KhosroshahiA, DeshpandeV, et al.. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum, 2012, 64(10): 3061-3067

[7] KhosroshahiA, BlochDB, DeshpandeV, et al.. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum, 2010, 62(6): 1755-1762

[8] KhosroshahiA, CarruthersMN, DeshpandeV, et al.. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore), 2012, 91(1): 57-66

[9] TabataT, KamisawaT, TakumaK, et al.. Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease. Intern Med, 2011, 50: 69-75

[10] MasakiY, KuroseN, YamamotoM, et al.. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol, 2012, 2012: 580814

[11] YamamotoM, TabeyaT, NaishiroY, et al.. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol, 2012, 22(3): 419-25

[12] EbboM, GradosA, BernitE, et al.. Pathologies associated with serum IgG4 elevation. Int J Rheumatol, 2012, 2012: 602809

[13] StoneJH, ZenY, DeshpandeV, et al.. IgG4-related disease. N Engl J Med, 2012, 366: 1643-1647